You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2025

List of Excipients in API palonosetron


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing palonosetron

Glossary
CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Accord Healthcare Inc PALONOSETRON HYDROCHLORIDE palonosetron hydrochloride 16729-365 CITRIC ACID MONOHYDRATE
Avyxa Pharma LLC POSFREA palonosetron 83831-105 MANNITOL
Avyxa Pharma LLC POSFREA palonosetron 83831-105 SODIUM ACETATE
Avyxa Pharma LLC POSFREA palonosetron 83831-105 WATER
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry

Subscribe to access the full database, or Try for Free

Showing 1 to 4 of 4 entries

Detailed excipient profiles for palonosetron

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: BUTYLATED HYDROXYANISOLE

Excipient focus: CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: EDETATE DISODIUM

Excipient focus: GLYCERIN

Excipient focus: GLYCINE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: MANNITOL

Excipient focus: POLYGLYCERYL-10 OLEATE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM CITRATE

palonosetron drug variants containing SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group